| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ALPINE IMMUNE SCIENCES, INC. | Chief Accounting Officer | Common Stock | 0 | $0 | $6.33 | 20 May 2024 | Direct |
| ALPINE IMMUNE SCIENCES, INC. | Chief Accounting Officer | Stock Option (Right to buy) | 0 | 20 May 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000162619924000091-fuhs-ulrich-martin-2024-05-20 | ALPINE IMMUNE SCIENCES, INC. | 20 May 2024 | 5 | $0 | 4 | Chief Accounting Officer | 20 May 2024, 20:03 |
| /report/000162619924000072-fuhs-ulrich-martin-2024-05-08 | ALPINE IMMUNE SCIENCES, INC. | 08 May 2024 | 2 | +$275,437 | 4 | Chief Accounting Officer | 10 May 2024, 19:22 |
| /report/000201811924000003-fuhs-ulrich-martin-2024-04-03 | ALPINE IMMUNE SCIENCES, INC. | 03 Apr 2024 | 0 | $0 | 3 | Chief Accounting Officer | 05 Apr 2024, 19:11 |